Meeder Asset Management’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-89
Closed -$1K 2366
2020
Q3
$1K Buy
+89
New +$1.61K ﹤0.01% 2094
2020
Q2
Sell
-3
Closed 2634
2020
Q1
$0 Sell
3
-3,691
-100% -$81.8K ﹤0.01% 2617
2019
Q4
$91K Buy
3,694
+2,797
+312% +$56.7K 0.01% 820
2019
Q3
$16K Buy
897
+648
+260% +$11.8K ﹤0.01% 1396
2019
Q2
$6K Sell
249
-6,194
-96% -$167K ﹤0.01% 1638
2019
Q1
$206K Buy
6,443
+839
+15% +$26K 0.02% 545
2018
Q4
$159K Buy
5,604
+3,825
+215% +$112K 0.01% 551
2018
Q3
$51K Sell
1,779
-2,208
-55% -$66.3K ﹤0.01% 779
2018
Q2
$149K Buy
3,987
+3,388
+566% +$133K 0.01% 555
2018
Q1
$24K Buy
599
+406
+210% +$14.8K ﹤0.01% 855
2017
Q4
$6K Sell
193
-15
-7% -$450 ﹤0.01% 1287
2017
Q3
$6K Sell
208
-136
-40% -$4.03K ﹤0.01% 1230
2017
Q2
$10K Sell
344
-138
-29% -$3.12K ﹤0.01% 1003
2017
Q1
$8K Hold
482
﹤0.01% 930
2016
Q4
$6K Buy
+482
New +$6.24K ﹤0.01% 841
2016
Q3
Sell
-6,063
Closed -$78K 998
2016
Q2
$78K Buy
6,063
+1,875
+45% +$29.4K 0.01% 686
2016
Q1
$80K Hold
4,188
0.01% 707
2015
Q4
$94K Sell
4,188
-14,283
-77% -$282K 0.01% 632
2015
Q3
$432K Buy
+18,471
New +$510K 0.04% 413

Other funds holding XENT

Meeder Asset Management's XENT Position: Q4 2020 in Review

Meeder Asset Management sold out of Intersect ENT, Inc (XENT) in Q4 2020, closing a stake of 89 shares — an estimated $1K sold.

Meeder Asset Management first reported a position in XENT in Q3 2015 and held it in 19 quarters. The position peaked at $432K in Q3 2015. 110 funds tracked by Wall St. Rank hold XENT as of Q4 2020.

  • Meeder Asset Management reported no remaining Intersect ENT, Inc position as of Q4 2020 after selling out during the quarter.
  • Meeder Asset Management sold 89 Intersect ENT, Inc shares in Q4 2020, an estimated $1K.
  • Meeder Asset Management first reported a position in Intersect ENT, Inc in Q3 2015 and held it in 19 quarters.
  • Meeder Asset Management's Intersect ENT, Inc position peaked at $432K in Q3 2015.
  • 110 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2020.

Based on Meeder Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.